the effect of combined herbal capsule on glycemic indices and lipid profile in patients with type 2 diabetes mellitus: a randomized controlled clinical trial

Objectives: the present study aimed to investigate the potential effects of the combined herbal capsule (chc), as a nutritional supplement, on glycemic indices (gis) and lipid profile (lp) of patients with type 2 diabetes mellitus (t2dm).methods: following a randomized, single-blind, placebo-controlled clinical trial, the current study was conducted on 80 cases with t2dm who were randomly assigned into two groups of treatment (chcs; n = 40) and control (placebo; n = 40). both groups received the intervention (500 mg capsules) twice a day for three months, without changes in the previous dose of oral anti-hyperglycemic drugs. the gi and lp levels were measured before the intervention and three months later to investigate the potential efficacy of the interventions.results: for those in the intervention group, the mean gi [i.e., fasting blood sugar, two hours postprandial (2hpp), and hba1c] was significantly different after 3 months (p < 0.05). the gi- and lp-related outcomes (tg, ldl-c except for tc) were improved after 3-month of receiving the intervention compared to the control group; however, the observed improvement was no statistically significant (p > 0.05). the hdl-c level was also significantly improved in the intervention group compared to the control group (p < 0.05).conclusions: this study demonstrated that receiving chcs could improve gi and lp levels (tg, ldl-c, and hdl-c, except for tc), which indicates its potential to control t2dm. moreover, no significant side effect was observed in the intervention group. it can be argued that the use of chcs, as adjuvant therapy, in combination with conventional hypoglycemic and lipid-lowering drugs, as well as following a modified lifestyle, not only can significantly enhance glycemic control but also may prevent t2dm complications.